ATS 2024 Final Program

Click on the session title to view the speakers

333

WEDNESDAY • MAY 22

therapeutic equivalence utilizing comparative clinical information. Discussion of recent generic product approvals and posted regulatory guidance will provide the audience a greater understanding of the generic approval process, and how the use of emerging technologies and outcomes of research projects contribute to scientific understanding for these complex orally inhaled and nasal drug products to inform regulatory actions. 12:00 Introduction 12:03 What is a Generic Drug, Anyway, and What Does It Mean for Me? 12:20 Emerging Concepts and New Technologies for Bioequivalence of Orally Inhaled and Nasal Drug Product 12:37 Update for Generic Orally Inhaled and Nasal Drug Products 12:54 Question and Answer Session

present the NHLBI program “An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications”. Based on a national network of 17 academic centers, the program aims to develop and implement pre-, intra- and post-operative interventions to reduce those complications. We will discuss specific topics of perioperative research, study design, preliminary physiological investigations, and implementation and initial results of the recently concluded national study on 750 patients undergoing major abdominal surgery with mechanical ventilation. 12:00 Postoperative Pulmonary Complications: Relevance, International Studies, and Challenges of Perioperative Research 12:15 Phase I/II Study, Personalized Intraoperative Mechanical Ventilation, Trial Design, and Implementation 12:30 Mechanism and Biomarkers of Perioperative Lung Injury 12:45 The Impact of a Bundle of Perioperative Interventions in the Improvement of Postoperative Pulmonary Outcomes

NHLBI, NIH MID-DAY SESSION

MD32 POSTOPERATIVE PULMONARY

COMPLICATIONS: FROM PHYSIOLOGY AND BIOLOGY TO A PREVENTIVE PERIOPERATIVE CLINICAL TRIAL

12:00 p.m. - 1:00 p.m.

San Diego Convention Center Room 30A-B (Upper Level)

Target Audience Health care providers (i.e., internists; anesthesiologists; surgeons; nurses; respiratory, physical/occupational therapists) and trainees caring for patients undergoing surgery; researchers interested in lung injury and perioperative lung injury. Objectives At the conclusion of this session, the participant will be able to: • more appropriately refer to reliable and up-to-date literature in the field of perioperative pulmonary complications. • have new strategies to manage the care of patients, particularly high risk patients, undergoing surgery. • apply different strategies to stratify patients on their risk to develop postoperative pulmonary complications. Postoperative pulmonary complications are a major factor for morbidity and mortality to the 28 million patients a year undergoing hospital-based surgery in the US. The session will

ATS 2024 • San Diego, CA